Comparison of Two Soft-agar Methods for Assaying Chemosensitivity of Human Tumours in Vitro: Malignant Melanomas
Overview
Authors
Affiliations
Two soft-agar methods for assaying chemosensitivity of human cancers in vitro were compared with respect to colony morphology, plating efficiency (PE) and chemosensitivity of human melanomas. In 9 xenografts and 9 patients' biopsy specimens Method A (essentially that of Courtenay & Mills, 1978) gave considerably higher PE that Method B (essentially that of Hamburger & Salmon, 1977) and, in contrast to Method B, the number of colonies was proportional to the number of cells plated. Evidence was obtained that the observed differences in PE could be attributed to the low O2 concentration and the presence of rat red blood cells in Method A. Colony morphology was similar in the 2 assays. When cells from 4 xenografted melanomas were treated in vitro with DTIC, CCNU, vinblastine and abrin, and the inhibition of colony formation was assayed concurrently in the 2 soft-agar methods, the tumour cells appeared to be more sensitive to 3 of the drugs in Method B than in A. The results demonstrate that chemosensitivity data obtained with the 2 assays cannot be directly compared.
Exploring Importance and Regulation of Autophagy in Cancer Stem Cells and Stem Cell-Based Therapies.
Rahman M, Apu E, Rakib-Uz-Zaman S, Chakraborti S, Bhajan S, Taleb S Cells. 2024; 13(11.
PMID: 38891090 PMC: 11171866. DOI: 10.3390/cells13110958.
Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions.
Dogan E, Kisim A, Bati-Ayaz G, Kubicek G, Pesen-Okvur D, Miri A Adv Nanobiomed Res. 2021; 1(11).
PMID: 34927168 PMC: 8680587. DOI: 10.1002/anbr.202100017.
The production of 3D tumor spheroids for cancer drug discovery.
Sant S, Johnston P Drug Discov Today Technol. 2017; 23:27-36.
PMID: 28647083 PMC: 5497458. DOI: 10.1016/j.ddtec.2017.03.002.
Pre-clinical evaluation of tyrosine kinase inhibitors for treatment of acute leukemia.
Christoph S, Lee-Sherick A, Sather S, DeRyckere D, Graham D J Vis Exp. 2013; (79):e50720.
PMID: 24084362 PMC: 3923888. DOI: 10.3791/50720.
Brain metastases of metastatic malignant melanoma: response to DTIC and interferon-gamma.
Schadendorf D, Worm M, Czarnetzki B J Neurooncol. 1993; 16(1):77-9.
PMID: 8410146 DOI: 10.1007/BF01324838.